[Brainlife] Newsletter, Vol.3, Suppl.4

top

BRAINLIFE NEWSLETTER

Volume 3, Supplement 4 - 1 October 2004	Volume 3 Archive

The Art of Oncology
	David N. Korones Taking Time Journal of Clinical Oncology, Vol 21, Issue 17 (September 1), 2003: 3366-3367. (Reflection, Reference & Full Text)

Astrocytoma
	Kasumi Araki, Kazuhiko Nozaki, Tetsuya Ueba, Masaaki Tatsuka and Nobuo Hashimoto High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas J Neurooncol. 2004 Mar-Apr;67(1-2):53-64. (Laboratory Investigation, Abstract)
	Michael D. Prados, Charles Scott, Walter J. Curran, Jr, Diana F. Nelson, Steve Leibel, Simon Kramer Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine or PCV Adjuvant Chemotherapy Journal of Clinical Oncology, Vol 17, Issue 11 (November 1), 1999: 3389-3395. (Retrospective Study, Abstract & Full Text)

Education
	Society for Neuroscience Brain Facts Copyright © 2002 Society for Neuroscience

Ependymoma
	Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas Am J Pathol. 1999 Aug;155(2):627-32. (Basic Science Study, Abstract & Full Text)

Gliomas
	Webster K. Cavenee Genetics and new approaches to cancer therapy Carcinogenesis, Vol. 23, No. 5, 683-686, May 2002. (Commentary, Reference & Full Text)
	The Neuro-Oncology Working Group Of The German Cancer Society Neuro-oncology working group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma J Clin Oncol. 2003 Sep 1;21(17):3276-84 (Clinical Study, Abstract & Full Text)
	Nieder C Treatment of newly diagnosed glioblastoma multiforme J Clin Oncol. 2002 Jul 15;20(14):3179-80; author reply 3181-2. (Correspondence, Reference & Full Text)
	Mark Noble Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage? PNAS, November 7, 2000, vol. 97 no. 23, 12393-12395 (Commentary, Reference & Full Text)

Meningioma
	Angel Maíllo, Alberto Orfao, José María Sayagués, Pedro Díaz, Juan Antonio Gómez-Moreta, Marcelino Caballero, David Santamarta, Angel Santos-Briz, Francisco Morales, María Dolores Tabernero New Classification Scheme for the Prognostic Stratification of Meningioma on the Basis of Chromosome 14 Abnormalities, Patient Age, and Tumor Histopathology Journal of Clinical Oncology, Vol 21, Issue 17 (September 1), 2003: 3285-3295. (Laboratory Investigation, Abstract & Full Text)

Pediatric Brain Tumors
	Roger J. Packer, James G. Gurney, Judy A. Punyko, Sarah S. Donaldson, Peter D. Inskip, Marilyn Stovall, Yutaka Yasui, Ann C. Mertens, Charles A. Sklar, H. Stacy Nicholson, Lonnie K. Zeltzer, Joseph P. Neglia, Leslie L. Robison Long-Term Neurologic and Neurosensory Sequelae in Adult Survivors of a Childhood Brain Tumor: Childhood Cancer Survivor Study Journal of Clinical Oncology, Vol 21, Issue 17 (September 1), 2003: 3255-3261. (Clinical Study, Abstract & Full Text)

Tumors
	C. Norman Coleman, James B. Mitchell Clinical Radiosensitization: Why It Does and Does Not Work J Clin Oncol, Vol 17, Issue 1 (January 1), 1999: 1. (Editorial, Reference & Full Text)